Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients With Debilitating Movement Disorder Tardive Dyskinesia
Teva宣佈Deutetrabenazine在歐洲患有令人痛苦的運動障礙晚發性運動障礙患者中的長期療效和安全性
Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients With Debilitating Movement Disorder Tardive Dyskinesia
Teva宣佈Deutetrabenazine在歐洲患有令人痛苦的運動障礙晚發性運動障礙患者中的長期療效和安全性
譯文內容由第三人軟體翻譯。